» Articles » PMID: 22359248

Long-term Prognosis of Patients with Cardiac Syndrome X: a Review

Overview
Journal Neth Heart J
Date 2012 Feb 24
PMID 22359248
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Follow-up studies of patients with cardiac syndrome X (CSX) generally report good prognosis. However, some recent studies report an adverse outcome for women.

Methods And Results: Structured literature search and meta-analysis for studies regarding prognosis of cardiac syndrome X patients. We identified 85 studies, ultimately selecting 16 for inclusion. Meta-analysis yielded a pooled major cardiac event percentage of 1.5% per 5 years and a pooled vascular event percentage of 4.8% per 5 years (n = 16 studies, n = 1694 patients). Fourteen studies reported upon the recurrence rate of angina pectoris: the pooled percentage of angina recurrence was 55% (n = 1336 patients).

Conclusion: The present review of recent archival literature demonstrates an overall major cardiac event rate of 1.5% per 5 years. Although this is an excellent prognosis for CSX patients, the quality of life is impaired because of the high recurrence rate of angina pectoris (55%).

Citing Articles

Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging.

Ayub M, Kalra D Diagnostics (Basel). 2020; 10(9).

PMID: 32916881 PMC: 7555249. DOI: 10.3390/diagnostics10090679.


Non-pharmacological Treatment of Refractory Angina and Microvascular Angina.

Rakhimov K, Gori T Biomedicines. 2020; 8(8).

PMID: 32823683 PMC: 7460172. DOI: 10.3390/biomedicines8080285.


Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?.

Iyngkaran P, Chan W, Liew D, Zamani J, Horowitz J, Jelinek M World J Methodol. 2019; 9(1):1-19.

PMID: 30705870 PMC: 6354077. DOI: 10.5662/wjm.v9.i1.1.


Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.

Sciacchitano S, Lavra L, Morgante A, Ulivieri A, Magi F, De Francesco G Int J Mol Sci. 2018; 19(2).

PMID: 29373564 PMC: 5855601. DOI: 10.3390/ijms19020379.


Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.

Mejia-Renteria H, van der Hoeven N, van de Hoef T, Heemelaar J, Ryan N, Lerman A Int J Cardiovasc Imaging. 2017; 33(7):1041-1059.

PMID: 28501910 DOI: 10.1007/s10554-017-1136-9.


References
1.
Herzog B, Husmann L, Valenta I, Gaemperli O, Siegrist P, Tay F . Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009; 54(2):150-6. DOI: 10.1016/j.jacc.2009.02.069. View

2.
Scholz M, Wegener K, Unverdorben M, Klepzig H . [Long-term outcome in patients with angina-like chest pain and normal coronary angiograms]. Herz. 2003; 28(5):413-20. DOI: 10.1007/s00059-003-2295-0. View

3.
Haude M, Baumgart D, Verna E, Piek J, Vrints C, Probst P . Intracoronary Doppler- and quantitative coronary angiography-derived predictors of major adverse cardiac events after stent implantation. Circulation. 2001; 103(9):1212-7. DOI: 10.1161/01.cir.103.9.1212. View

4.
Lindsay Jr J, Pinnow E, Pichard A . Frequency of major adverse cardiac events within one month of coronary angioplasty: a useful measure of operator performance. J Am Coll Cardiol. 1999; 34(7):1916-23. DOI: 10.1016/s0735-1097(99)00449-0. View

5.
Gulati M, Cooper-DeHoff R, McClure C, Johnson B, Shaw L, Handberg E . Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009; 169(9):843-50. PMC: 2782882. DOI: 10.1001/archinternmed.2009.50. View